Dopamine D2 receptor model explains binding affinity of neuroleptics: piquindone and its structure activity relationships.
Teeter
M M
MM
Department of Chemistry, Boston College, Chestnut Hill, MA 02167, USA.
Durand
C J
CJ
D014150:Antipsychotic Agents / Q000737:chemistry* / Q000378:metabolism; D001436:Bacteriorhodopsins / Q000737:chemistry / Q000378:metabolism; D001665:Binding Sites; D019204:GTP-Binding Proteins / Q000737:chemistry / Q000378:metabolism; D007546:Isoquinolines / Q000737:chemistry* / Q000378:metabolism; D008958:Models, Molecular; D008968:Molecular Conformation; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D017448:Receptors, Dopamine D2 / Q000737:chemistry* / Q000378:metabolism; D012243:Rhodopsin / Q000737:chemistry / Q000378:metabolism; D013329:Structure-Activity Relationship
D014150:Antipsychotic Agents; D007546:Isoquinolines; D017448:Receptors, Dopamine D2; D001436:Bacteriorhodopsins; D012243:Rhodopsin; D019204:GTP-Binding Proteins; C032412:Ro 22-1319